Regeneron Pharmaceuticals (REGN) EBIT (2009 - 2026)
Regeneron Pharmaceuticals' EBIT came in at $1.29 billion for Q2 2026, up 19.8% from $1.08 billion a year earlier and up 101.2% from the prior quarter.
Powered by 
Analysis
Regeneron Pharmaceuticals (REGN) EBIT (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Regeneron Pharmaceuticals reported EBIT of $3.84 billion, up 0.1% year-over-year; for FY2025, it was $3.58 billion, down 10.3% from FY2024.
- EBIT has declined in each of the last four years, with a five-year compound annual growth rate of 0.0% (FY2020 to FY2025).
- Going back by year, EBIT was $3.99 billion in FY2024 (-1.4%), $4.05 billion in FY2023 (-14.6%), $4.74 billion in FY2022 (-47.0%) and $8.95 billion in FY2021 (+150.1%).
- The Q2 2026 figure represents the highest quarterly EBIT since Q4 2021.
- Year-over-year, EBIT increased in five of the last eight quarters, with an average decline of 1.0%.
- The fastest year-over-year change in EBIT over five years came in Q4 2021 (growth of 126.2%), and the weakest in Q2 2022 (a decline of 66.8%).
- Business Quant data shows REGN's EBIT at $642.9 million (Q1 2026), $879.9 million (Q4 2025) and $1.03 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 11.75 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 7.14 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 6.43 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | -10.39 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 4.27 Bn |
| 10 | Regeneron Pharmaceuticals | 81.27 Bn | 47.47 Bn | 3.71 Bn | 1.29 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.29 Bn |
| Mar 31, 2026 | 642.90 Mn |
| Dec 31, 2025 | 879.90 Mn |
| Sep 30, 2025 | 1.03 Bn |
| Jun 30, 2025 | 1.08 Bn |
| Mar 31, 2025 | 591.70 Mn |
| Dec 31, 2024 | 990.20 Mn |
| Sep 30, 2024 | 1.18 Bn |
| Jun 30, 2024 | 1.07 Bn |
| Mar 31, 2024 | 751.40 Mn |
| Dec 31, 2023 | 972.90 Mn |
| Sep 30, 2023 | 1.11 Bn |
| Jun 30, 2023 | 1.02 Bn |
| Mar 31, 2023 | 946.70 Mn |
| Dec 31, 2022 | 1.15 Bn |
| Sep 30, 2022 | 1.22 Bn |
| Jun 30, 2022 | 1.11 Bn |
| Mar 31, 2022 | 1.26 Bn |
| Dec 31, 2021 | 2.64 Bn |
| Sep 30, 2021 | 1.85 Bn |
API Access
Regeneron Pharmaceuticals EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=REGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "REGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=REGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();